Literature DB >> 13839326

Nature of the thrombin-inhibiting effect of incubated fibrinogen.

D C TRIANTAPHYLLOPOULOS.   

Abstract

Entities:  

Keywords:  FIBRINOGEN/pharmacology; THROMBIN/antagonists

Mesh：

Substances：

Year:  1959        PMID： 13839326     DOI： 10.1152/ajplegacy.1959.197.3.575

Source DB:  PubMed          Journal:  Am J Physiol        ISSN： 0002-9513


× No keyword cloud information.
  4 in total

1.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

2.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

3.  [On the demonstration and occurrence and the importance of the intracorporeal origin of fibrinogen breakdown products with special consideration of the demonstration of high molecular fibrin breakdown products in menstrual blood].

Authors:  R Marx; W Weinzierl; G Schwick; K Störiko
Journal:  Blut       Date:  1965-10

4.  Congenital dysfibrinogenemia: fibrinogen Detroit.

Authors:  E F Mammen; A S Prasad; M I Barnhart; C C Au
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.